4th Circ. Says Execs' Optimism Wasn't Fraud In Merger Suit
By Katryna Perera · July 24, 2023, 4:55 PM EDT
The Fourth Circuit on Monday affirmed a lower court's dismissal of a class action from investors of two merged pharmaceutical companies who said the companies and their executives were too optimistic...
To view the full article, register now.